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Abstract
Background: Spinocerebellar ataxia type 17 (SCA17), a neurodegenerative disorder in man, is
caused by an expanded polymorphic polyglutamine-encoding trinucleotide repeat in the gene for
TATA-box binding protein (TBP), a main transcription factor. Observed pathogenic expansions
ranged from 43 – 63 glutamine (Gln) codons (Gln43–63). Reduced penetrance is known for Gln43–48
alleles. In the vast majority of families with SCA17 an expanded CAG repeat interrupted by a CAA
CAG CAA element is inherited stably.
Results: Here, we report the first pedigree with a Gln49 allele that is a) not interrupted, b) unstable
upon transmission, and c) associated with reduced penetrance or very late age of onset. The 76-
year-old father of two SCA17 patients carries the Gln49 TBP allele but presents without obvious
neurological symptoms. His children with Gln53 and Gln52 developed ataxia at the age of 41 and 50.
Haplotype analysis of this and a second family both with uninterrupted expanded and unstable
pathological SCA17 alleles revealed a common core genotype not present in the interrupted
expansion of an unrelated SCA17 patient. Review of the literature did not present instability in
SCA17 families with expanded alleles interrupted by the CAA CAG CAA element.
Conclusion: The presence of a Gln49 SCA17 allele in an asymptomatic 76-year-old male reams the
discussion of reduced penetrance and genotypes producing very late disease onset. In SCA17,
uninterrupted expanded alleles of TBP are associated with repeat instability and a common founder
haplotype. This suggests for uninterrupted expanded alleles a mutation mechanism and some
clinical genetic features distinct from those alleles interrupted by a CAA CAG CAA element.
Background
The spinocerebellar ataxias (SCAs), a group of autosomal
dominantly inherited human disorders with mainly adult
age of onset, are caused by progressive neurodegeneration
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and significant cerebellar dysfunction, but also involve
other regions of the central or peripheral nervous system.
Clinically and even histopathologically the differentiation
between SCA subtypes may be rather difficult. Geneti-
cally, for 25 types causative mutations in various genes are
known or defined by linkage to distinct chromosomal
regions. For seven SCAs expanded CAG trinucleotide
repeats have been discovered [1]. This kind of mutation
seems to be specific for the human species.
SCA17 [OMIM: 607136], a rare type of SCA with a variety
of clinical features, is caused by an expanded CAG repeat
in TBP, the gene of the TATA box-binding protein [TBP;
OMIM: 600075]. TBP forms the DNA-binding subunit of
the universally essential RNA polymerase II transcription
factor D. TBP has been mapped close to the telomeric
region at chromosome 6q27 [2]. An imperfect repetitive
and polymorphic polyglutamine encoding CAG triplet
sequence is part of the coding region of TBP [3]. Initially,
20 different alleles coding for 29 to 42 glutamine residues
(Gln) have been identified [4] with the most common
alleles containing 32 to 39 Gln codons. The poly-
glutamine-encoding DNA sequence of TBP wildtype alle-
les can be subdivided into several regions including two
polymorphic (CAG)n stretches: (CAG)3 (CAA)3 (CAG)n
CAA CAG CAA (CAG)n CAA CAG. In patients with SCA17,
the polymorphic CAG sequence encoding the poly-
glutamine stretch of TBP is expanded heterozygous. Alle-
les with 43 – 48 Gln codons represent a zone of
incomplete penetrance or very late age of onset [5,6].
Disease causing alleles with up to 63 [7] Gln codons were
identified. Clinically, SCA17 may mimic a broad spec-
trum of neuropsychiatric diseases, including Parkinson
and Huntington disease, major psychosis, and multitudi-
nous cerebellar syndromes [8-10]. Neuropathological
findings include cerebellar, cortical, and subcortical atro-
phy, Purkinje cell loss, gliosis [11], and neuronal intranu-
clear inclusions immunopositive for TBP and
polyglutamine.
The clinical relevance of Gln43–48 encoding TBP alleles is
not obvious. A Gln43 allele was considered responsible for
clinical symptoms in a 64-year-old patient with ataxia and
progressive mental deterioration [6]. Gln44 repeats were
found in a patient with gait ataxia and behavioral changes
and a disease onset at 29 [12] and another patient with
early onset cerebellar ataxia (EOCA) and suspected Fried-
reich ataxia [5]. Regarding the EOCA phenotype in the lat-
ter patient, Gln44 was considered a large normal allele. On
the other hand, alleles for Gln46  [12] and Gln48  [13]
showed reduced penetrance in two families. Therefore,
Gln43–48 encoding alleles could present intermediate alle-
les with incomplete penetrance.
In contrast to the majority of other polyglutamine dis-
eases, the SCA17 repeat expansion shows meiotic stability
upon transmission. To date, only two pedigrees are
known in which instability of the repetitive sequence has
been observed, irrespectively of the gender of the trans-
mitting parent. In one case, the repeat increased by one
triplet after maternal transmission [5], while in the other
case an increase of 13 triplets and marked anticipation
was associated with paternal inheritance [14].
Here, we describe a SCA17 family from northern Ger-
many with a) repeat instability upon paternal transmis-
sion and b) reduced penetrance or very late onset in
association with an uninterrupted CAG41 sequence (Gln49
allele). Meiotic instability is not common in SCA17 pedi-
grees. Therefore, we performed haplotype analysis in two
unrelated families looking for a founder allele associated
with repeat instability at the SCA17 locus. In addition, we
included a patient homozygous for a SCA17 allele with a
CAG CAA CAG interrupting element to reveal independ-
ent mutation events for the different repeat compositions.
Results
Phenotype and genotype
In family A, two of four offspring of unaffected parents
(74- and 76-year-old) developed an adult onset ataxia.
The 43-year-old index patient reported onset of gait dis-
turbances accompanied by a slowly progressive dysarthria
at the age of 41. Brain magnetic resonance image analysis
performed approximately half a year after clinical onset
revealed cortical cerebellar atrophy and a mildly reduced
brain volume. His 56-year-old sister noticed symptoms of
gait ataxia, dysarthria, and disturbed handwriting at the
age of 50. The 76-year-old father of the siblings reported
that a neurological examination had revealed no abnor-
mality. Both parents presented without obvious neurolog-
ical signs. In order to clarify the repeat status of TBP and
the inheritance of the disease in the family, both agreed in
molecular genetic analysis for SCA17 but rejected the offer
of a detailed clinical neurological examination.
Molecular genetic analyses revealed pathogenic alleles for
the TBP gene: 53 repeats for the male patient with age of
onset at 41 and 52 repeats for his sister with symptoms
starting at 50 years of age. Their clinically non-affected 76-
year-old father carries an elongated allele of 49 repeats.
Therefore, this allele displays reduced penetrance or very
late onset, as well as instability upon transmission.
Sequence analysis revealed loss of the CAA CAG CAA
interruption in the expanded alleles.
Haplotype analysis
Recently, we described a family (B) with repeat instability
and missing CAA triplets at the expanded alleles [5,10].
Genealogic data for both families (A,B), as far as available,BMC Medical Genetics 2005, 6:27 http://www.biomedcentral.com/1471-2350/6/27
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revealed no relationship between the families. But North-
ern German ancestry of both families suggested the possi-
bility of a common founder. This was assessed by
haplotype analysis (figure 1) including the unrelated
patient H carrying homozygous an expansion in the TBP
gene [15]. In both families A and B, the same haplotype
consisting of allele 5 of D6S446 and allele 2 of D6S1590
(5_2) was located on the chromosome bearing the
expanded TBP allele co-segregating with SCA17, respec-
tively. Patient H did not share this haplotype, she is
homozygous for haplotype 2_4. Among the markers ana-
lyzed, D6S446 and D6S1590 were the ones most closely
located to TBP. Therefore, the data suggest the possibility
of a common SCA17 founder allele of the variably
expanded TBP allele in families A and B with further insta-
bility upon transmission.
Allele frequency
To estimate the probability of a founder effect, the allele
frequencies of D6S446 and D6S1590 were determined in
96 anonymous control subjects of the geographic region
of families A and B. For D6S446 six alleles were found, for
D6S1590 seven. Allele 5 of D6S446 is present in 43 out of
184 chromosomes (23%), allele 2 of D6S1590 in 92
(50%). The computed maximum likelihood frequencies
(using Arlequin software version 2.001) of the three most
common two-locus haplotypes of D6S446 and D6S1590
with frequencies > 0.1 are 0.219 (6_2), 0.163 (6_1), and
Pedigrees and haplotype analysis Figure 1
Pedigrees and haplotype analysis. Pedigrees of families A and B, including six-locus haplotypes based on five 6q-telomeric 
microsatellite markers (D6S1719, D6S264, D6S281, D6S446, D6S1590) and closely downstream located polymorphic poly-Gln 
encoding trinucleotide stretch within TBP. Alleles of the microsatellites are denoted by numbers 1 – 8, TBP alleles are denoted 
by the number of Gln-encoding trinucleotides. SCA17-linked alleles are boxed as well as the disease haplotype D6S446 and 
D6S1590.
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0.153 (5_2). Thus, the three most common haplotypes,
including the haplotype 5_2 co-segregating with SCA17 in
families A and B account for 53.5% of all haplotypes. The
17 remaining haplotypes predicted had computed fre-
quencies from 0.3–6.8%. Maximum likelihood frequency
of haplotype 4_2 (patient H) is 0.042. The likelihood
ratio test suggested a highly significant linkage disequilib-
rium between D6S446 and D6S1590 (p < 5 ×10-6).
Observed and maximum likelihood counts of genotypes
and haplotypes did not deviate significantly from Hardy
Weinberg equilibrium. Therefore, the likelihood of two
unrelated subjects sharing haplotype 5_2 is estimated to
be ~8 %. The combined likelihood that two unrelated
subjects affected by SCA17 share haplotype 5_2 and that
this haplotype co-segregates with SCA17 in both families
is ~2%. This strongly supports the view of a possible
founder haplotype of the SCA17 causing alleles in fami-
lies A and B.
Discussion
In comparison to other spinocerebellar ataxias, some
genetic features in SCA17 are remarkable: The majority of
pathological alleles contains an interspersed CAA CAG
CAA element separating the (CAG)n sequence into two
parts (table 1). In three SCA17 pedigrees known to date
the pathogenic allele lacks the CAA CAG CAA interruption
and is associated with instability and variable repeat
expansion upon transmission. Two of the three families
are of northern German origin and were investigated in
the study presented. In both families, SCA17 co-segregates
with an expanded, uninterrupted, and instable (CAG)n in
TBP located on chromosomes sharing a haplotype in the
close centromeric neighborhood of TBP, respectively (fig-
ure 1). Although the unstable repetitive sequence is linked
with one of the three more commonly prevalent haplo-
types, statistics point to a nominally significant likelihood
that our observation reflects a founder effect rather than
coincidence by chance.
In some cases, the expanded glutamine stretch may be the
consequence of an intragenic duplication. So, the first
published case with SCA17 is a Japanese girl with a de
novo duplication event in her paternal allele [7]. In addi-
tion, doubling of a stretch of 19 Gln codons was found in
a three-generation SCA17 pedigree [16]. Expanded poly-
glutamine stretches arising from duplications represent
rare events in SCAs. Similarly, a pathogenic elongation of
the polyalanine part within the polyadenylate binding
protein nuclear 1 resulting from duplication has been
described for oculopharyngeal muscular dystrophy [17].
The identification of these mutations gives support to the
hypothesis of unequal crossing-over as one possible
molecular mechanism for repeat expansions. In SCA17,
such rare unequal crossing-over events may have been the
causative mechanism underlying both the loss of the
interspersed CAA CAG CAA element and expansion of
(CAG)n. As discussed for SCA2 [18] the presence of CAA
interruptions in SCA17 alleles breaks the repetitive
sequence into shorter homogenous triplet tracts and may
thus protect it from instability by reducing the slippage
between the complementary strands.
In SCA17, there is a broad range of intermediate TBP alle-
les Gln43–48 associated with reduced penetrance. In other
SCA types, such intermediate alleles are rarely found
[19,20] or even unknown. However, intermediate alleles
Table 1: Review of Gln Repeats and SCA17 Alleles of 16 Unrelated Cases. Duplicated elements are boxed, instability by maternal (m) 
or paternal (p) inheritance.
Gln Case Repeat Composition Comments Ref.
49–53 familial (CAG)3 (CAA)3 (CAG)41–45 CAA CAG instability (p) here
63 sporadic (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)9 (CAA)3 (CAG)9 CAA CAG CAA (CAG)19 
CAA CAG
duplication [7]
47 familial (CAG)3 (CAA)3 (CAG)8 CAA CAG CAA (CAG)28 CAA CAG [16]
47 sporadic (CAG)3 (CAA)3 (CAG)6 CAA CAG CAA (CAG)30 CAA CAG
48 familial (CAG)3 (CAA)3 (CAG)6 CAA CAG CAA (CAG)31 CAA CAG
55 familial (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)16 CAA CAG CAA (CAG)16 CAA CAG duplication
51 familial (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)31 CAA CAG [5]
53 – 55 familial (CAG)3 (CAA)3 (CAG)45–47 CAA CAG instability (m)
48 familial (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)28 CAA CAG reduced penetrance [13]
47 sporadic (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)27 CAA CAG homozygous mutation [15]
46 familial (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)26 CAA CAG [21]
43 (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)26 CAA CAG [6]
53 – 66 familial (CAG)3 (CAA)4 (CAG)44/57 CAA CAG instability (p) [14]
44 sporadic (CAG)3 (CAA)3 (CAG)9 CAA CAG CAA (CAG)24 CAA CAG [12]
46 sporadic (CAG)3 (CAA)3 (CAG)11 CAA CAG CAA (CAG)24 CAA CAG reduced penetrance
48 familial (CAG)3 (CAA)3 (CAG)6 CAA CAG CAA (CAG)31 CAA CAG homozygous mutation [23]BMC Medical Genetics 2005, 6:27 http://www.biomedcentral.com/1471-2350/6/27
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represent a well-known finding in patients with Hunting-
ton disease [21]. We found (CAG/CAA)49 but no visible
symptoms at the age of 76 in the father of two SCA17
patients with expanded TBP alleles (CAG/CAA)52–53. This
large allele, (CAG/CAA)49, has not been found in control
samples. It may be of reduced penetrance, associated with
very late age of onset and/or low expression of clinical
signs. In addition, we performed haplotype analysis for a
sporadic patient with homozygosity of the intermediate
allele (CAG/CAA)47 and a rather progressive course [15].
Here, we cannot exclude the possibility of an additive
effect of two intermediate alleles with respect to patho-
genicity. In this patient, (CAG/CAA)47 is interrupted by
CAA CAG CAA and linked with D6S446/D6S1590 haplo-
type 2_4. Thus, both the type of TBP expansion and the
SCA17 linked haplotypes differ between the sporadic
homozygous and the familial cases presented and do not
point to a single founder. An extended analysis of intra-
genic markers in larger numbers of SCA17 families with
different types of expansions could reveal "mutation
prone" founder alleles differing with respect to the type of
mutation.
Conclusion
The extraordinary high variability of the clinical expres-
sion of pathological TBP repeat expansions in SCA17 is
further complicated by the occurrence of genetically insta-
ble repeats in association with the lack of an interspersing
CAA CAG CAA element. The degree of reduced penetrance
and very low expression of symptoms refer to strong mod-
ifying factors including potent influence of the genetic
background. Unless SCA17 is a rare type of dominantly
inherited ataxia, the repeat expansion within the TBP gene
arose at unrelated genotypes. This has to be taken into
account both in molecular genetic diagnostics and in
genetic counseling.
Methods
Molecular analysis and polymorphic markers
Genomic DNA was prepared from peripheral blood leu-
kocytes using standard protocols. SCA17 alleles were
amplified by PCR as described [7], separated on 6% dena-
turing polyacrylamide gels, and visualized by silver stain-
ing. For sequencing, PCR products were separated under
non-denaturing conditions using the dHPLC-HT-system
(WAVE Transgenomic). The eluted fragments were
sequenced using dye terminators and the automated cap-
illary sequencer Avant 3100 (Applied Biosystems). For
haplotype analysis, the highly polymorphic microsatellite
markers D6S1719, D6S264, D6S281, D6S446, and
D6S1590 were used as described [15]. Maximum likeli-
hood haplotype frequencies of two-locus haplotypes
based on markers D6S446 and D6S1590 genotyped in 96
unrelated anonymous control subjects and linkage dise-
quilibrium were analyzed using Arlequin software version
2.001 [22].
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